SCHEMBL7744477

SCHEMBL7744477

N#Cc1cnc(O)cn1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3674005 0.84 CHEK1 (0.44)
SCHEMBL24414334 0.80 CHEK1 (0.32)
SCHEMBL4584646 0.74
SCHEMBL610366 0.72
SCHEMBL29413210 0.72
SCHEMBL24942539 0.72 CHEK1 (0.38)
SCHEMBL19011572 0.70
SCHEMBL617986 0.70
SCHEMBL21663747 0.70
SCHEMBL305290 0.70

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2001009365-A1 PROCESS FOR THE PREPARATION OF 2-CYANO-5-HYDROXYPYRAZINE LONZA AG (CH) 2001-02-08 WO claimed
EP-3950692-A1 NOVEL TRICYCLIC COMPOUNDS AbbVie Inc. (US) 2022-02-09 EP disclosed
WO-2001009365-A1 PROCESS FOR THE PREPARATION OF 2-CYANO-5-HYDROXYPYRAZINE LONZA AG (CH) 2001-02-08 WO disclosed
WO-2001009365-A1 PROCESS FOR THE PREPARATION OF 2-CYANO-5-HYDROXYPYRAZINE LONZA AG (CH) 2001-02-08 WO disclosed